Roth Capital Partners will host its 5th Annual Healthcare Opportunities Conference on Sept. 29, 2026, at the Metropolitan Club in New York City. The invitation-only event will bring together C-suite executives from more than 30 public healthcare companies and leading institutional investors for a day of focused dialogue and networking.
The conference will feature one-on-one and small-group meetings with companies representing biotechnology, life science tools and diagnostics, and medical technology. These sessions are designed to facilitate direct engagement between corporate leadership and investors, offering insights into company strategies and sector dynamics.
In addition to the meetings, the event will include discussions on critical topics shaping the healthcare landscape. Panels will cover neuroscience, drug pricing and coverage, regulatory uncertainty, and capital constraints in biotechnology. A session will also address minimal residual disease (MRD) monitoring in solid tumors, highlighting advances in precision oncology.
The conference will be hosted by ROTH senior healthcare research analysts Jonathan Aschoff, Ph.D., Max Masucci, Boobalan Pachaiyappan, Ph.D., and Adam Walsh, MD. Their expertise across biotechnology, diagnostics, and medical technology will guide the conversations and provide context for investors navigating a complex sector.
ROTH’s track record in healthcare underscores the significance of this gathering. Since 2010, the firm has been involved in more than 600 transactions for healthcare clients, representing more than $25 billion in total transaction value. This depth of experience positions ROTH as a key player in facilitating capital formation and strategic advisory in the life sciences.
For those interested in attending or learning more about the event, the full calendar of events is available at https://ibn.fm/vDTjP. Additional information about ROTH can be found at www.roth.com.
The conference is powered by InvestorWire, a specialized communications platform focused on advanced wire-grade press release syndication. InvestorWire is part of the Dynamic Brand Portfolio at IBN, which delivers access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and a full array of tailored corporate communications solutions.
This conference matters because it provides a platform for healthcare companies to engage directly with institutional investors at a time when the sector faces significant headwinds. Regulatory uncertainty, drug pricing pressures, and capital constraints are top of mind for executives and investors alike. By fostering these conversations, ROTH aims to help companies secure the funding and partnerships needed to advance innovation. For investors, the event offers a chance to identify emerging opportunities in biotechnology, diagnostics, and medical technology. As the healthcare industry continues to evolve, gatherings like this play a vital role in shaping investment strategies and driving growth.
